FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic antidepressant citalopram from Mylan Pharmaceuticals. This approval enables the generic to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)